drugset / Trial / NCT02412761

Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

NCT02412761

RandomizedCrossoverSingle-blindTreatment

Summary

Children are increasingly being diagnosed with essential hypertension and the absence of comparative effectiveness research in antihypertensive therapies has contributed to considerable differences in prescribing practices among physicians treating children with essential hypertension. This study will consist of a series of systematically-administered n-of-1 trials among children to verify the need for ongoing antihypertensive treatment and if so, to identify the preferred single drug therapy.

Timeline

Start
2013-06
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg Oral
Comparator Hydrochlorothiazide Unknown 3 mg/kg Oral
Comparator Hydrochlorothiazide Unknown 50 mg Oral
Comparator LISINOPRIL ANHYDROUS Small molecule 0.6 mg/kg Oral
Comparator LISINOPRIL ANHYDROUS Small molecule 40 mg Oral